Background ANCA associated vasculitis (AAV) is an autoimmune disease with significant
morbidity and mortality, in which diagnostic delay is associated with worse outcomes. AAV is …

ANCA-associated vasculitis (AAV) can present in an atypical manner and obscure the
clinical picture. We sought to characterize clinical characteristics and outcomes in these …

Introduction The complement system has an important role in the pathogenesis of vasculitis
associated with antineutrophilic cytoplasmic antibody (AAV) mainly at the level of the …

Objectives ANCA-associated vasculitis (AAV) is a rare autoimmune disorder that commonly
involves the kidney. Early identification of kidney involvement, assessing treatment …

An overlap of systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic
antibodies‐(ANCA‐) associated vasculitis (AAV) is extremely rare: approximately 40 cases …

Objective To investigate the occurrence of venous thromboembolic events (VTE) in a large
cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis …

Systemic lupus erythematosus (SLE) and small-sized vessel vasculitis are usually two
distinguishable autoimmune diseases. However, a vasculitis may be found in the course …

ANCA-associated vasculitis (AAV) is characterized by inflammation and destruction of small
and medium-sized vessels. Current management strategies for AAV have been validated in …

Objective Therapeutic advances in ANCA-associated vasculitis (AAV) have improved patient
survival, but mortality rates remain higher than the general population. Glucocorticoids …

Objective Renal involvement in anti-neutrophil cytoplasm antibody (ANCA)-associated
vasculitis is associated with significant morbidity and higher mortality rates. This study …